Magic shotguns versus magic bullets: selectively non-selective drugs for mood disorders and schizophrenia
Open accessThe DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Alterations in GPCR signalling are implicated in the pathogenesis and treatment of neuropsychiatric55, immunological56, gastrointestinal57,58, cardiac59, renal, hormonal, infectious60 and many other disorders53,54.”
From Unexplored therapeutic opportunities in the human genome (2018) · cites this paper as [55]
In the citing paper
“most clinically effective antipsychotics also exhibit a myriad of other actions that contribute to both therapeutic and side-effect profiles [359,360].”
From Reward circuitry dysfunction in psychiatric and neurodevelopmental disorders and genetic syndromes: animal models and clinical findings (2012) · cites this paper as [360]
In the citing paper
“This often generates beneficial therapeutic activities,102 due to additive or synergistic pharmacological effects.103”
From QSAR without borders (2020) · cites this paper as [102]
Citations
Cites
Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants
Santarelli, L., Saxe, M., Gross, C., Surget, A., Battaglia, F., Dulawa, S., Weisstaub, N., Lee, J., Duman, R., Arancio, O., et al. (2003) · Science · doi:10.1126/science.1083328 · Cited by 4,321
Clozapine for the Treatment-Resistant Schizophrenic: A Double-blind Comparison With Chlorpromazine
Kane, J. (1988) · Archives of General Psychiatry · doi:10.1001/archpsyc.1988.01800330013001 · Cited by 4,156
(2003) · The Lancet · doi:10.1016/s0140-6736(03)12705-5 · Cited by 1,706
Meltzer, H. Y. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.1.82 · Cited by 1,393
Meltzer, H. Y., Matsubara, S., & Lee, J. C. (1989) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)20710-8 · Cited by 1,349
Nichols, D. E. (2004) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2003.11.002 · Cited by 1,211
Genome Scan Meta-Analysis of Schizophrenia and Bipolar Disorder, Part II: Schizophrenia
Lewis, C. M., Levinson, D. F., Wise, L. H., DeLisi, L. E., Straub, R. E., Hovatta, I., Williams, N. M., Schwab, S. G., Pulver, A. E., Faraone, S. V., et al. (2003) · The American Journal of Human Genetics · doi:10.1086/376549 · Cited by 1,137
The Effects of Clozapine, Risperidone, and Olanzapine on Cognitive Function in Schizophrenia
Meltzer, H. Y., & McGurk, S. R. (1999) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a033376 · Cited by 1,020
Aripiprazole, A Novel Atypical Antipsychotic Drug with a Unique and Robust Pharmacology
Shapiro, D. A., Renock, S., Arrington, E., Chiodo, L. A., Liu, L.-X., Sibley, D. R., Roth, B. L., & Mailman, R. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300203 · Cited by 968
Self-citationBurris, K. D., Molski, T. F., Xu, C., Ryan, E., Tottori, K., Kikuchi, T., Yocca, F. D., & Molinoff, P. B. (2002) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.033175 · Cited by 922
Research works printed but not linked: 1
- Hemrick–Luecke, S. et al. Pharmacological activity of aripiprazole at presynaptic and postsynaptic dopamine receptors and in antipsychotic models. Proc. Soc. Neurosci. 894.9 (2002).
Cited by
Items 901–1,000 of 1,000
Quantitative Prioritization of Tool Compounds for Phenotypic Screening
Wang, Y., & Jenkins, J. L. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-7847-2_15 · Cited by 5
Neuroprotective Effects of the Psychoactive Compound Biatractylolide (BD) in Alzheimer’s Disease
Hu, Q., Wang, J., Irshad, M., Mao, S., Chen, H., Song, Y., Xu, X., & Feng, X. (2022) · Molecules · doi:10.3390/molecules27238294 · Cited by 5
Yu, Z., Wu, Z., Zhou, M., Chen, L., Li, W., Liu, G., & Tang, Y. (2023) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2023.107831 · Cited by 5
Statins and tissue mineralization: Putative involvement of alkaline phosphatase
Negrão, M. R., Mota, A., Azevedo, I., & Martins, M. J. (2006) · Medical Hypotheses · doi:10.1016/j.mehy.2006.02.046 · Cited by 5
Prata, D. P., Gafoor, R., Kay, V. A., Arranz, M. J., Munro, J., & McGuire, P. K. (2012) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e31825ec2cb · Cited by 5
Cassels, B. K., & Asencio, M. (2008) · Natural Product Communications · doi:10.1177/1934578x0800300422 · Cited by 5
Data Mining Using Ligand Profiling and Target Fishing
Bryant, S. D., & Langer, T. (2013) · Methods and principles in medicinal chemistry · doi:10.1002/9783527655984.ch11 · Cited by 5
Zaade, D., Schmitz, J., Benke, E., Klare, S., Seidel, K., Kirsch, S., Goldin-Lang, P., Zollmann, F. S., Unger, T., & Funke‐Kaiser, H. (2013) · PLoS ONE · doi:10.1371/journal.pone.0057674 · Cited by 7
Design of novel multiple-acting ligands towards SERT and 5-HT2C receptors
Éliás, O., Ágai-Csongor, É., Domány, G., Keserű, G. M., Gere, A., Kiss, B., Hellinger, É., Vastag, M., & Gyertyán, I. (2014) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2014.03.043 · Cited by 6
Tomić, M., Vasković, D., Tovilović-Kovačević, G., Andrić, D. B., Penjišević, J. Z., & Kostić‐Rajačić, S. (2011) · Archiv der Pharmazie · doi:10.1002/ardp.200900168 · Cited by 5
Davies, M. A., Conley, Y. P., & Puskar, K. R. (2010) · Perspectives In Psychiatric Care · doi:10.1111/j.1744-6163.2010.00245.x · Cited by 5
Ingenuity Pathway Analysis of Clozapine-Induced Obesity
Myslobodsky, M. S. (2008) · Obesity Facts · doi:10.1159/000127278 · Cited by 6
Beaulieu, J. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13846 · Cited by 5
Iatrogenic hypertension: a bioinformatic analysis
Botzer, A., Finkelstein, Y., Grossman, E., Moult, J., & Unger, R. (2018) · The Pharmacogenomics Journal · doi:10.1038/s41397-018-0062-0 · Cited by 5
Melatonin Receptors in Central Nervous System
Dubocovich, M. L. (2007) · Wiley eBooks · doi:10.1002/9780470101001.hcn047 · Cited by 5
Opportunities and Challenges in Precision Neurotherapeutics
Mujica-Parodi, L. R., Öngür, D., & Richardson, R. M. (2026) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-110824-031709 · Cited by 4
Miyamoto, S., Merrill, D. B., Jarskog, L. F., Fleishhacker, W. W., Marder, S. R., & Lieberman, J. A. (2015) · Wiley eBooks · doi:10.1002/9781118753378.ch104 · Cited by 5
R software for QSAR analysis in phytopharmacological studies
Ningthoujam, S. S., Nath, R., Kityania, S., Mazumder, P. B., Choudhury, M. D., Talukdar, A. D., Nahar, L., & Sarker, S. D. (2023) · Phytochemical Analysis · doi:10.1002/pca.3239 · Cited by 4
Synchrotron Radiation: A Key Tool for Drug Discovery
Li, F., Liu, R., Li, W., Xie, M., & Qin, S. (2024) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2024.129990 · Cited by 4
Role of A 2A R-D2R Dimerization and D 2 R-Biased Signaling in PDE10A-Mediated Cardiac Hypertrophy
Chen, S., Fan, X., Xu, S., Zhu, N., Shi, H., Jin, Z. G., & Chen, Y. (2025) · Circulation · doi:10.1161/circulationaha.125.075465 · Cited by 5
Éliás, O., Kovács, Z. Z., Wágner, G., Némethy, Z., Tarcsay, Á., & Greiner, I. (2016) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2016.07.055 · Cited by 4
Li, H. Q., Xu, J. Y., Gao, Y., & Jin, L. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.09.030 · Cited by 4
Network Pharmacology for Drug Repositioning in Anti-Alzheimer’s Drug Development
Dash, R., Munni, Y. A., Mitra, S., Dash, N., & Moon, I. S. (2023) · Neuromethods · doi:10.1007/978-1-0716-3311-3_15 · Cited by 5
TarMGDif: Target-Specific Molecular Graphs Generation Based on Diffusion Model
Wang, S., Zhang, Y., Liang, D., Dong, K., & Song, T. (2025) · IEEE Journal of Biomedical and Health Informatics · doi:10.1109/jbhi.2025.3569105 · Cited by 5
The Emergence of Serotonin 5‐HT 2B Receptors as DRUG Antitargets
Setola, V., & Roth, B. L. (2008) · Methods and principles in medicinal chemistry · doi:10.1002/9783527621460.ch7 · Cited by 5
Self-citationExperimental Medicine in Psychiatry New Approaches in Schizophrenia, Depression and Cognition
Dawson, G. R. (2015) · Current topics in behavioral neurosciences · doi:10.1007/7854_2015_5016 · Cited by 4
Veselinović, T., Vernaleken, I., Cumming, P. D., Henning, U., Winkler, L., Kaleta, P., Paulzen, M., Luckhaus, C., & Gründer, G. (2018) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s148557 · Cited by 4
The Efficiency of Multi-target Drugs: A Network Approach
Alberca, L. N., & Talevi, A. (2020) · Human perspectives in health sciences and technology · doi:10.1007/978-3-030-32857-3_3 · Cited by 4
Strategies of Polypharmacology
Wang, Z., & Yang, B. (2022) · Springer eBooks · doi:10.1007/978-3-031-04998-9_2 · Cited by 6
Transformation of a Dopamine D2 Receptor Agonist to Partial Agonists as Novel Antipsychotic Agents
Liu, R., Qi, J., Wang, H., Fan, L., Zhang, P., Yu, J., Tan, L., Wang, S., & Cheng, J. (2023) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.3c00098 · Cited by 4
Perspective Chapter: The Role of Dopamine Receptors in Neuropsychiatric Diseases
Yaman, B. (2023) · IntechOpen eBooks · doi:10.5772/intechopen.112320 · Cited by 4
Molecular Interaction Fingerprints
Rognan, D., & Desaphy, J. (2013) · Methods and principles in medicinal chemistry · doi:10.1002/9783527665143.ch14 · Cited by 4
de Diego, A. M. G., Lorrio, S., Hernández-Guijo, J. M., Gandía, L., & de Diego, A. M. G. (2012) · Wiley eBooks · doi:10.1002/9781118185537.ch4 · Cited by 4
Winsauer, P. J., Moerschbaecher, J. M., & Roussell, A. M. (2008) · Journal of the Experimental Analysis of Behavior · doi:10.1901/jeab.2008.89-225 · Cited by 4
Kroeze, W. K., & Roth, B. L. (2006) · Journal of Psychopharmacology · doi:10.1177/1359786806066045 · Cited by 6
Self-citationIdentifying the In Vivo Cellular Correlates of Antipsychotic Drugs
Joshi, R., & Panicker, M. M. (2018) · eNeuro · doi:10.1523/eneuro.0220-18.2018 · Cited by 6
Hong, E. Y., Lee, S., Yun, H., & Kim, B. (2021) · Frontiers in Catalysis · doi:10.3389/fctls.2021.774512 · Cited by 4
Introduction: The Case for Polypharmacology
Hopkins, A. L. (2012) · Wiley eBooks · doi:10.1002/9781118098141.ch · Cited by 6
Gandini, A., Prati, F., Uliassi, E., & Bolognesi, M. L. (2017) · Methods and principles in medicinal chemistry · doi:10.1002/9783527674381.ch6 · Cited by 3
Design and Semisynthesis of Aminocannabinoids as Neurological Magic Shotguns
Stryker, Z. I., Cutler, S. J., Francis, T. C., & León, F. (2025) · Journal of Natural Products · doi:10.1021/acs.jnatprod.5c01236 · Cited by 3
Liu, B., Chen, Z., Li, N., Li, N., Zhang, W., Li, Y., Huang, X., Li, M., & Li, X. (2026) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.5c02639 · Cited by 3
A brief history of clozapine use in Taiwan
Lin, S., & Lane, H. (2023) · Schizophrenia Research · doi:10.1016/j.schres.2023.06.006 · Cited by 3
In Vitro Safety Pharmacology Profiling: An Important Tool to Decrease Attrition
Hamon, J., & Whitebread, S. (2009) · Methods and principles in medicinal chemistry · doi:10.1002/9783527627448.ch12 · Cited by 3
Ahn, S., & Phillips, A. G. (2013) · ACS Chemical Neuroscience · doi:10.1021/cn400040r · Cited by 3
Fifty years of Biochemical Pharmacology: The discipline and the journal
Enna, S. J., FEUERSTEIN, G. Z., Piette, J. G., & Williams, M. J. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.03.024 · Cited by 6
Partial agonism and fast dissociation of LASSBio-579 at dopamine D2 receptor
Pompeu, T. E. T., do Monte, F. M., Bosier, B., Fraga, C. A. M., Barreiro, E. J., Menegatti, R., Hermans, E., & Noël, F. (2015) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2015.04.003 · Cited by 4
da Silva, A. P., Chiari, L. P. A., Guimarães, A. R., Honório, K. M., & da Silva, A. B. F. (2021) · Structural Chemistry · doi:10.1007/s11224-021-01742-w · Cited by 3
Gülfidan, G., Beklen, H., Sinha, I., Kucukalp, F., Caloglu, B., Esen, I., Turanlı, B., Ayyildiz, D., Arğa, K. Y., & Sinha, R. (2021) · OMICS A Journal of Integrative Biology · doi:10.1089/omi.2021.0085 · Cited by 3
Mishra, R. K., Mishra, A., & Gupta, A. (2022) · Research Journal of Pharmacy and Technology · doi:10.52711/0974-360x.2022.00484 · Cited by 3
Ethnopharmacology and the Development of Psychoactive Drug: A Critical Overview
Elisabetsky, E. (2022) · Springer eBooks · doi:10.1007/978-3-030-62059-2_459 · Cited by 3
Rajagopal, L., Mahjour, S., Huang, M., Ryan, C., Elzokaky, A., Csakai, A., Orr, M. J., Scheidt, K. A., & Meltzer, H. Y. (2023) · Behavioural Brain Research · doi:10.1016/j.bbr.2023.114614 · Cited by 5
2-Bromoterguride–a potential atypical antipsychotic drug without metabolic effects in rats
Franke, R. T., Tarland, E., Fink, H., Pertz, H. H., & Brosda, J. (2016) · Psychopharmacology · doi:10.1007/s00213-016-4356-0 · Cited by 3
Computational Strategies to Incorporate GPCR Complexity in Drug Design
Martí-Solano, M., Kaczor, A. A., Guixà-González, R., & Selent, J. (2015) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9781608058648115010003 · Cited by 3
Agonist-Directed Trafficking of 5-HT Receptor-Mediated Signal Transduction
Berg, K. A., & Clarke, W. P. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-080-5_6 · Cited by 3
Predictive Toxicology: Latest Scientific Developments and Their Application in Safety Assessment
Armstrong, D., Li, S., Frieauff, W., Martus, H. ‐., Reilly, J., Mikhailov, D., Whitebread, S., & Urbán, L. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-409547-2.12367-4 · Cited by 3
The ontology reference model for visual selectivity analysis in drug-target interactions
Cheng, Q., Lopez, F. A., Duran, C., Camarillo, C., Oprea, T. I., & Schürer, S. C. (2017) · IEEE International Conference on Bioinformatics and Biomedicine (BIBM) · doi:10.1109/bibm.2017.8217982 · Cited by 3
Psychedelic drugs as a long-needed innovation in psychiatryPreprint
Oña, G., & Bouso, J. C. (2020) · Qeios · doi:10.32388/t3em5e.2 · Cited by 3
A fluorescent biosensor for the visualization of agmatinePreprint
Kröger, P., Stiel, A. C., Stüven, B., Shanmugaratnam, S., Schoch, S., Wachten, D., & Höcker, B. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.07.27.605435 · Cited by 3
Giatro, S. M., Komontachakis, G., Kalantidou, A., Lesgidou, N., Karageorgos, V., Teleb, M., Islam, M. R., Mavromoustakos, T., Fahmy, H. T. Y., Venihaki, M., et al. (2025) · Biomolecules · doi:10.3390/biom15091265 · Cited by 2
Maio, A. D., Bassareo, V., Simone, G. D., HASSAN, A., Bertolino, A., Errico, F., Rampino, A., de Bartolomeis, A., & Usiello, A. (2026) · Schizophrenia · doi:10.1038/s41537-025-00722-x · Cited by 2
Computational Approaches for the Discovery of Natural Lead Structures
Rollinger, J. M., & Wolber, G. (2011) · CRC Press eBooks · doi:10.1201/b11196-5 · Cited by 2
A Gene Family-led Meta-Analysis of Drug-Target Interactions
Cheng, Q., Mehta, S., & Schürer, S. C. (2018) · IEEE International Conference on Bioinformatics and Biomedicine (BIBM) · doi:10.1109/bibm.2018.8621087 · Cited by 2
Leahy, E., Varney, M. A., & Brunner, D. (2020) · Royal Society of Chemistry eBooks · doi:10.1039/9781839160721-00175 · Cited by 3
Fondjo, L. A., Osei, O., Owiredu, W. K. B. A., Obirikorang, C., Senu, E., Owusu‐Antwi, R., & Brefo, E. F. J. (2022) · Health Science Reports · doi:10.1002/hsr2.858 · Cited by 2
Antidiabetic agents: Do they hit the right targets?
Zhao, Y., Zhang, X., Liang, H., & Wang, L. (2022) · Frigid Zone Medicine · doi:10.2478/fzm-2022-0030 · Cited by 2
The Polypharmacology of Cariprazine and its Implications to Clinical Indications
Egyed, A., Kiss, D. J., & Keserű, G. M. (2024) · Wiley eBooks · doi:10.1002/9781394182862.ch25 · Cited by 2
Hong, H., Donlon, J., Schaefer, M., Sarkar, S., Bugarski‐Kirola, D., Shad, M. U., Hou, W., Kirschner, M., Varghese, S. P., Mitrev, L. V., et al. (2025) · Clinical Drug Investigation · doi:10.1007/s40261-025-01465-4 · Cited by 3
Overview of Current Drug Discovery and Development with an Eye towards the Future
Izet, M. (2011) · InTech eBooks · doi:10.5772/39073 · Cited by 2
Loss-of-function genetic diseases and the concept of pharmaceutical targets
Ségalat, L. (2007) · Nature Reviews Genetics · doi:10.1038/nrg1828-c1 · Cited by 2
Pharmacological aspects of cognitive impairment: past, present and future of drugs in dementia
Isensee, K., Petroianu, G. A., & Stark, H. (2007) · Journal of Applied Biomedicine · doi:10.32725/jab.2007.008 · Cited by 5
Knowledge‐Based and Computational Approaches to In Vitro Safety Pharmacology
Scheiber, J., Bender, A., Azzaoui, K., & Jenkins, J. L. (2009) · Methods and principles in medicinal chemistry · doi:10.1002/9783527627448.ch13 · Cited by 2
De Novo Design of Ligands against Multitarget Profiles
Besnard, J., & Hopkins, A. L. (2013) · Wiley eBooks · doi:10.1002/9783527677016.ch12 · Cited by 2
Mining Scientific and Clinical Databases to Identify Novel Uses for Existing Drugs
Andronis, C., Sharma, A., Deftereos, S., Virvilis, V., Konstanti, O., Persidis, A., & Persidis, A. (2012) · Wiley eBooks · doi:10.1002/9781118274408.ch6 · Cited by 2
Newman, A. H., & Rothman, R. B. (2007) · Elsevier eBooks · doi:10.1016/b0-08-045044-x/00167-x · Cited by 3
Setola, V. (2005) · OhioLink ETD Center (Ohio Library and Information Network) · Cited by 2
Is it Time to Revisit the Current R&D Model?
O’Connell, D. P., Hopkins, A. L., & Roblin, D. (2007) · International Journal of Pharmaceutical Medicine · doi:10.2165/00124363-200721050-00004 · Cited by 2
Comprendre les effets latéraux des antipsychotiques atypiques
Plaze, M. (2008) · L Encéphale · doi:10.1016/s0013-7006(08)75521-0 · Cited by 2
Wood, M. W., Wesolowski, S. S., Widzowski, D., & Cross, A. J. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.10.008 · Cited by 2
Éliás, O., Nógrádi, K., Domány, G., Szakács, Z., Kóti, J., Szántay, C., Tarcsay, Á., Keserű, G. M., Gere, A., Kiss, B., et al. (2015) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2015.12.071 · Cited by 2
Zhao, G. (2011) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/w4vm-f755 · Cited by 2
Clinical Need and Rationale for Multi-Target Drugs in Psychiatry
Shahid, M. (2012) · Royal Society of Chemistry eBooks · doi:10.1039/9781849734912-00014 · Cited by 2
The application of molecular topology for ulcerative colitis drug discovery
Bellera, C. L., Ianni, M. E. D., & Talevi, A. (2017) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2018.1396314 · Cited by 2
Learning reference-enriched approach towards large scale active ontology alignment and integration
Cheng, Q., Ursu, O., Oprea, T. I., & Schürer, S. C. (2017) · IEEE International Conference on Bioinformatics and Biomedicine (BIBM) · doi:10.1109/bibm.2017.8217908 · Cited by 2
Silva, R. R., Parreiras‐e‐Silva, L. T., Pompeu, T. E. T., Duarte, D. Â., Fraga, C. A. M., Barreiro, E. J., Menegatti, R., Costa-Neto, C. M., & Noël, F. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00628 · Cited by 2
Olubiyi, O. O., Idowu, T. O., Ogundaini, A. O., & Orhuah, G. (2019) · Current Computer - Aided Drug Design · doi:10.2174/1573409915666190702111023 · Cited by 3
Genetic basis of schizophrenia: Basic hypothesis pathways and gene functions
Tanrıkulu, A. (2020) · Demiroglu Science University Florence Nightingale Transplantation Journal · doi:10.5606/dsufnjt.2020.012 · Cited by 2
Gründer, G. (2011) · Springer eBooks · doi:10.1007/978-3-642-19844-1_55 · Cited by 2
Riemer, C. (2012) · Wiley eBooks · doi:10.1002/9781118098141.ch17 · Cited by 2
Derangement model of ligand-receptor binding
Williams, M. (2022) · Computational and Mathematical Biophysics · doi:10.1515/cmb-2022-0137 · Cited by 2
The Magic Shotgun: Does It Fit the Clinician and Will It Point at Schizophrenia?
Mortimer, A. M. (2011) · Springer eBooks · doi:10.1007/978-94-007-0834-1_2 · Cited by 2
Ingestion-Controlling Network: What's Language Got to Do with It?
Myslobodsky, M. S., & Coppola, R. (2010) · Reviews in the Neurosciences · doi:10.1515/revneuro.2010.21.1.67 · Cited by 2
Gray, J. A., & Roth, B. L. (2007) · Wiley eBooks · doi:10.1002/9780470101001.hcn008 · Cited by 2
Self-citationNo evidence for direct physical interaction of 5-HT 2A -mGluR2 receptors in vitro or in vivoPreprint
Fordyce, B. A., Chiu, Y.-T., Wright, N. J., Sakamoto, K., Lyons, S. P., Webb, T. S., Tilton, H. E., Walsh, J. J., Marek, G. J., Setola, V., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.06.28.734515 · Cited by 2
Self-citationDopamine D2 Receptor Functional Selectivity as a Mechanism of Atypical Antipsychotic Drug Action
Urban, J. D. (2006) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/q8t3-p159 · Cited by 1
Alisauskiene, R., Johnsen, E., Gjestad, R., Kroken, R. A., Jørgensen, H. A., & Løberg, E. (2021) · Substance Use & Misuse · doi:10.1080/10826084.2021.1958858 · Cited by 1
COMT, DRD1, DRD2, DRD4: Genetic evidence for the dopamine hypothesis in schizophrenia
Dong, D. (2022) · AIP conference proceedings · doi:10.1063/5.0112965 · Cited by 1
Luo, Y., Qiu, Y., Lin, Y., Li, Q., Fu, L., Xu, X., Shi, Y., Lu, T., Wei, X., Xu, X., et al. (2025) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2025.117993 · Cited by 1
Lu, Q., Zhao, Y., Xu, X., Guo, P., Arés, I., Martínez, M., López-Torres, B., Martínez‐Larrañaga, M., Anadón, A., Pan, Y., et al. (2025) · Biochemical Pharmacology · doi:10.1016/j.bcp.2025.117420 · Cited by 1
Egyed, A., Kiss, D. J., Pável, Z., Rajna, K., Gaitonde, S. A., Dubiel, M., Loza, M. I., Szűcs, E., Borbély, É., Hajna, Z., et al. (2025) · European Journal of Medicinal Chemistry Reports · doi:10.1016/j.ejmcr.2025.100302 · Cited by 2
Large Library Docking for Polypharmacology
Wu, Y., Vigneron, S. F., Bráz, J. M., Srinivasan, K., Fink, E. A., Huang, X.-P., Xu, X., Huebner, H., Kim, J. Y., Wang, J., et al. (2026) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5c03810 · Cited by 2
Self-citation
Metadata
- Authors
- Roth, B. L., Sheffler, D. J., & Kroeze, W. K.
- Affiliations
- Case Western Reserve University (US)
- Corresponding author
- Roth, Bryan L.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2004-04
- Volume
- 3
- Issue
- 4
- Pages
- 353-359
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W2122995608
- Cited by
- 1,155
- References
- 63
- Citations by year
- 2026: 29 · 2025: 28 · 2024: 37 · 2023: 39 · 2022: 47 · 2021: 49 · 2020: 49 · 2019: 63 · 2018: 46 · 2017: 42 · 2016: 61 · 2015: 65 · 2014: 58 · 2013: 73 · 2012: 83
- FWCI
- 4.42
- Type
- journal article
- Language
- en
- Open access
- green
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Drug Discovery (publishedVersion)
- PubMed (publishedVersion)
- Carolina Digital Repository (University of North Carolina at Chapel Hill) (submittedVersion)
- UNC Libraries
- Funders
- National Institutes of Health
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- Keywords
- magic bullet, polygenic disease, mood disorders, schizophrenia, depression, bipolar disorder, central nervous system disorders, drug target selectivity, polypharmacology, antipsychotic drug development
- MeSH terms
- Humans, Schizophrenia, Antipsychotic Agents, Drugs, Investigational, Comorbidity, Mood Disorders, Substance-Related Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.